share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer O'Hara Elaine

诺瓦瓦克斯医药 | 4:持股变动声明-高管 O'Hara Elaine

SEC announcement ·  03/05 19:34
Moomoo AI 已提取核心信息
On March 1, 2024, Elaine O'Hara, EVP and Chief Strategy Officer of Novavax Inc (NVAX), completed a stock transaction involving the company's common stock. O'Hara acquired 19,600 shares at a price of $5.39 per share through the exercise of derivative securities. On the same day, she disposed of 5,375 shares at the same price, which was related to the payment of exercise price or tax liability by delivering or withholding securities. After these transactions, O'Hara's direct holdings in Novavax common stock amounted to 14,225 shares. The total market value of the disposed shares was calculated to be $28,971.25.
On March 1, 2024, Elaine O'Hara, EVP and Chief Strategy Officer of Novavax Inc (NVAX), completed a stock transaction involving the company's common stock. O'Hara acquired 19,600 shares at a price of $5.39 per share through the exercise of derivative securities. On the same day, she disposed of 5,375 shares at the same price, which was related to the payment of exercise price or tax liability by delivering or withholding securities. After these transactions, O'Hara's direct holdings in Novavax common stock amounted to 14,225 shares. The total market value of the disposed shares was calculated to be $28,971.25.
2024年3月1日,Novavax Inc(NVAX)执行副总裁兼首席战略官伊莱恩·奥哈拉完成了一项涉及该公司普通股的股票交易。奥哈拉通过行使衍生证券,以每股5.39美元的价格收购了19,600股股票。同日,她以相同价格出售了5,375股股票,这与通过交付或预扣证券支付行使价或纳税义务有关。在这些交易之后,奥哈拉直接持有的Novavax普通股为14,225股。经计算,已处置股票的总市值为28,971.25美元。
2024年3月1日,Novavax Inc(NVAX)执行副总裁兼首席战略官伊莱恩·奥哈拉完成了一项涉及该公司普通股的股票交易。奥哈拉通过行使衍生证券,以每股5.39美元的价格收购了19,600股股票。同日,她以相同价格出售了5,375股股票,这与通过交付或预扣证券支付行使价或纳税义务有关。在这些交易之后,奥哈拉直接持有的Novavax普通股为14,225股。经计算,已处置股票的总市值为28,971.25美元。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息